Sahil Maheshwari - Akums Drugs General Strategy
| AKUMS Stock | 458.70 7.30 1.57% |
Executive
Sahil Maheshwari is General Strategy of Akums Drugs and
| Address | Akums House,, Delhi, India, 110083 |
| Phone | 91 11 6904 1000 |
| Web | https://www.akums.in |
Akums Drugs Management Efficiency
The company has return on total asset (ROA) of 0.0522 % which means that it generated a profit of $0.0522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1817 %, meaning that it generated $0.1817 on every $100 dollars invested by stockholders. Akums Drugs' management efficiency ratios could be used to measure how well Akums Drugs manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of September 2025, Other Current Assets is likely to grow to about 2.1 B, while Total Assets are likely to drop about 38.4 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Dhaval Pandya | Parag Milk Foods | N/A | |
| G Srikkanth | Spencers Retail Limited | N/A | |
| Samir Kedia | Praxis Home Retail | 44 | |
| Mukesh Agrawal | LT Foods Limited | N/A | |
| Puneet Bura | Sindhu Trade Links | N/A | |
| Rahul Prakash | Praxis Home Retail | N/A | |
| Sanjeev Uppal | LT Foods Limited | 45 | |
| Sachin Shah | Parag Milk Foods | N/A | |
| Palash Aggarwal | LT Foods Limited | N/A | |
| Vikash Agarwal | Spencers Retail Limited | 43 | |
| Prashant Barfe | Praxis Home Retail | 47 | |
| K Subramaniam | LT Foods Limited | N/A | |
| Ashish Bhutda | Praxis Home Retail | N/A | |
| Arvind Desai | Parag Milk Foods | N/A | |
| Mirna Duskan | LT Foods Limited | N/A | |
| Shankar Satappagol | LT Foods Limited | N/A | |
| Bhawani Parmar | Sindhu Trade Links | N/A | |
| Binod Das | Parag Milk Foods | N/A | |
| Amit Parmar | Osia Hyper Retail | N/A | |
| Vikas Magoon | LT Foods Limited | N/A | |
| Sunil Alagh | LT Foods Limited | 78 | |
Management Performance
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0522 |
Akums Drugs Leadership Team
Elected by the shareholders, the Akums Drugs' board of directors comprises two types of representatives: Akums Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akums. The board's role is to monitor Akums Drugs' management team and ensure that shareholders' interests are well served. Akums Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akums Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amrut Medhekar, Chief Business | ||
| Sanjeev Jain, MD CoFounder | ||
| Arushi Jain, Director Excellence | ||
| Sumeet Sood, Chief Officer | ||
| Sandeep Jain, MD Founder | ||
| Jitendra Mishra, Head Technology | ||
| Arvind Srivastava, President Resource | ||
| Sanjay Sinha, President Director | ||
| Sunil Jaiswal, Vice Development | ||
| Shantanu Chobhe, Corporate Head | ||
| Dharamvir Malik, Company Officer | ||
| Sahil Maheshwari, General Strategy | ||
| Sanjay Sharma, New Strategy | ||
| Rajkumar Bafna, President Finance |
Akums Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Akums Drugs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0522 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 66.38 B | ||||
| Shares Outstanding | 153.1 M | ||||
| Shares Owned By Insiders | 84.92 % | ||||
| Shares Owned By Institutions | 9.22 % | ||||
| Price To Book | 2.34 X | ||||
| Price To Sales | 1.70 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.